| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-08 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-08 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.31 | 1e-08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.29 | 3e-08 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.28 | 4e-08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-08 |